Russell Investments Group
KYNB

Russell Investments Group’s Kyntra Bio KYNB Stock Holding History

Russell Investments Group’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,836
Closed -$28.3K – 3730
2024
Q3 		$28.3K Buy
2,836
+89
+3% +$1.34K ﹤0.01% 2891
2024
Q2 		$61.3K Buy
2,747
+201
+8% +$6.21K ﹤0.01% 2726
2024
Q1 		$150K Buy
2,546
+19
+0.8% +$819 ﹤0.01% 2506
2023
Q4 		$56K Sell
2,527
-153
-6% -$2.31K ﹤0.01% 2626
2023
Q3 		$57.8K Sell
2,680
-2,899
-52% -$114K ﹤0.01% 2730
2023
Q2 		$377K Buy
5,579
+31
+0.6% +$12.8K ﹤0.01% 2306
2023
Q1 		$2.59M Sell
5,548
-2,063
-27% -$1.09M 0.01% 1420
2022
Q4 		$3.05M Buy
7,611
+3,353
+79% +$1.28M 0.01% 1342
2022
Q3 		$1.38M Sell
4,258
-428
-9% -$138K ﹤0.01% 1767
2022
Q2 		$1.24M Sell
4,686
-433
-8% -$111K ﹤0.01% 1846
2022
Q1 		$1.54M Sell
5,119
-737
-13% -$257K ﹤0.01% 1761
2021
Q4 		$2.06M Sell
5,856
-1,229
-17% -$383K ﹤0.01% 1787
2021
Q3 		$1.81M Sell
7,085
-1,995
-22% -$707K ﹤0.01% 1890
2021
Q2 		$6.05M Buy
9,080
+6,260
+222% +$3.61M 0.01% 1229
2021
Q1 		$2.39M Sell
2,820
-2,321
-45% -$2.47M ﹤0.01% 1772
2020
Q4 		$4.77M Sell
5,141
-1,038
-17% -$1.09M 0.01% 1260
2020
Q3 		$6.35M Buy
6,179
+3,879
+169% +$4.17M 0.01% 999
2020
Q2 		$2.33M Buy
2,300
+20
+0.9% +$18.6K 0.01% 1544
2020
Q1 		$1.98M Buy
2,280
+33
+1% +$32.8K 0.01% 1470
2019
Q4 		$2.41M Buy
2,247
+316
+16% +$323K ﹤0.01% 1628
2019
Q3 		$1.79M Buy
1,931
+46
+2% +$50.5K ﹤0.01% 1737
2019
Q2 		$2.13M Hold
1,885
– – ﹤0.01% 1645
2019
Q1 		$2.56M Sell
1,885
-57
-3% -$77.3K ﹤0.01% 1590
2018
Q4 		$2.25M Buy
1,942
+695
+56% +$781K 0.01% 1553
2018
Q3 		$1.89M Buy
1,247
+976
+360% +$1.5M ﹤0.01% 1788
2018
Q2 		$423K Sell
271
-81
-23% -$106K ﹤0.01% 2447
2018
Q1 		$407K Buy
352
+164
+87% +$216K ﹤0.01% 2522
2017
Q4 		$229K Sell
188
-427
-69% -$535K ﹤0.01% 2634
2017
Q3 		$827K Sell
615
-1,685
-73% -$1.78M ﹤0.01% 2231
2017
Q2 		$1.86M Buy
2,300
+955
+71% +$665K ﹤0.01% 1776
2017
Q1 		$829K Buy
1,345
+494
+58% +$301K ﹤0.01% 2200
2016
Q4 		$462K Buy
+851
New +$425K ﹤0.01% 2492

Other funds holding KYNB

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Russell Investments Group's KYNB Position: Q4 2024 in Review

Russell Investments Group sold out of Kyntra Bio (KYNB) in Q4 2024, closing a stake of 2,836 shares — an estimated $28.3K sold.

Russell Investments Group first reported a position in KYNB in Q4 2016 and held it in 32 quarters. The position peaked at $6.35M in Q3 2020. 68 funds tracked by Wall St. Rank hold KYNB as of Q4 2024.

  • Russell Investments Group reported no remaining Kyntra Bio position as of Q4 2024 after selling out during the quarter.
  • Russell Investments Group sold 2,836 Kyntra Bio shares in Q4 2024, an estimated $28.3K.
  • Russell Investments Group first reported a position in Kyntra Bio in Q4 2016 and held it in 32 quarters.
  • Russell Investments Group's Kyntra Bio position peaked at $6.35M in Q3 2020.
  • 68 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2024.

Based on Russell Investments Group's 13F filing for Q4 2024, filed 13 Feb 2025.